Precipio Inc (PRPO)
5.80
-0.15
(-2.53%)
USD |
NASDAQ |
May 03, 16:00
5.95
+0.15
(+2.59%)
After-Hours: 20:00
Precipio Enterprise Value: 7.135M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 7.135M |
| May 02, 2024 | 7.350M |
| May 01, 2024 | 6.877M |
| April 30, 2024 | 7.063M |
| April 29, 2024 | 7.278M |
| April 26, 2024 | 7.457M |
| April 25, 2024 | 7.671M |
| April 24, 2024 | 7.221M |
| April 23, 2024 | 7.635M |
| April 22, 2024 | 7.893M |
| April 19, 2024 | 7.707M |
| April 18, 2024 | 8.429M |
| April 17, 2024 | 8.429M |
| April 16, 2024 | 8.473M |
| April 15, 2024 | 8.473M |
| April 12, 2024 | 8.356M |
| April 11, 2024 | 8.348M |
| April 10, 2024 | 8.348M |
| April 09, 2024 | 7.921M |
| April 08, 2024 | 8.150M |
| April 05, 2024 | 7.878M |
| April 04, 2024 | 7.836M |
| April 03, 2024 | 7.871M |
| April 02, 2024 | 8.107M |
| April 01, 2024 | 8.622M |
| Date | Value |
|---|---|
| March 28, 2024 | 8.422M |
| March 27, 2024 | 7.712M |
| March 26, 2024 | 7.541M |
| March 25, 2024 | 7.421M |
| March 22, 2024 | 7.388M |
| March 21, 2024 | 7.388M |
| March 20, 2024 | 7.388M |
| March 19, 2024 | 7.715M |
| March 18, 2024 | 7.502M |
| March 15, 2024 | 7.502M |
| March 14, 2024 | 7.360M |
| March 13, 2024 | 7.644M |
| March 12, 2024 | 7.828M |
| March 11, 2024 | 7.715M |
| March 08, 2024 | 7.658M |
| March 07, 2024 | 7.502M |
| March 06, 2024 | 7.956M |
| March 05, 2024 | 7.873M |
| March 04, 2024 | 8.297M |
| March 01, 2024 | 8.070M |
| February 29, 2024 | 8.293M |
| February 28, 2024 | 8.305M |
| February 27, 2024 | 8.070M |
| February 26, 2024 | 7.938M |
| February 23, 2024 | 7.658M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
4.948M
Minimum
Sep 21 2023
105.59M
Maximum
May 20 2021
23.69M
Average
16.40M
Median
Apr 21 2022
Enterprise Value Benchmarks
| Bruker Corp | 11.24B |
| Azenta Inc | 1.995B |
| Harvard Bioscience Inc | 199.37M |
| Bionano Genomics Inc | 31.43M |
| Akoya Biosciences Inc | 190.66M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.925M |
| Revenue (Quarterly) | 4.329M |
| Total Expenses (Quarterly) | 5.183M |
| EPS Diluted (Quarterly) | 0.88 |
| Gross Profit Margin (Quarterly) | 46.50% |
| Profit Margin (Quarterly) | 21.37% |
| Earnings Yield | -78.62% |
| Normalized Earnings Yield | -78.62 |